RepliCel Life Sciences Inc. | Balance Sheet
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,958.00
2,035.10
175.80
1,510.80
497.10
2,418.50
Total Accounts Receivable
24.50
29.10
25.80
66.10
48.50
74.80
Other Current Assets
46.60
51.20
193.20
236.10
289.20
510.70
Total Current Assets
2,029.10
2,115.40
394.80
1,812.90
834.90
3,004
Net Property, Plant & Equipment
23.30
25.90
21.10
15.30
11.20
8.20
Total Assets
2,052.40
2,141.30
415.90
1,828.20
846.00
3,227.40
Accounts Payable
369.40
-
-
-
-
Other Current Liabilities
-
335.10
1,017.70
621.70
1,166.00
Total Current Liabilities
369.40
335.10
1,017.70
621.70
1,166.00
Other Liabilities
208.40
-
-
-
-
Total Liabilities
577.70
335.10
1,017.70
621.70
1,166.00
Common Equity (Total)
1,474.70
1,806.20
601.80
1,206.50
320.00
Total Shareholders' Equity
1,474.70
1,806.20
601.80
1,206.50
320.00
Total Equity
1,474.70
1,806.20
601.80
1,206.50
320.00
Liabilities & Shareholders' Equity
2,052.40
2,141.30
415.90
1,828.20
846.00
About RepliCel Life Sciences
View Profile
